CTAC Patient Input Survey on Sofosbuvir

On October 15, 2013, CTAC conducted a webinar supporting our patient input submission for sofosbuvir, a new NS5B inhibitor to treat hepatitis C. This webinar was just one step you, people with lived experience and service providers can take to support this important patient input submission on sofosbuvir – a medication that stands to change the face of hepatitis C treatment.

Please forward this information through your networks, encouraging people to take the following actions:

  1. To learn more about sofosbuvir, watch a recorded version of the webinar on CTAC’s YouTube channel. The video is available here: http://www.youtube.com/watch?v=IYdZsCPKvnA (please note: due to resource constraints, the webinar is only available in English)
  2. Have your say! From your experience living with or working with people living with hepatitis C, do you think sofosbuvir could improve treatment? Fill out our survey to have your voice included in our patient input submission: http://www.surveymonkey.com/s/YPPYS7D

PLEASE NOTE: The survey will be open only until Sunday, October 20 at 11:59PM, so respond soon!

If you have questions, contact Paul Sutton, Policy Researcher, CTAC:

Office:  1-877-237-2822 or 416-410-6538 ext 224 Email: [email protected]